What is China Everbright Limited (CEVIY) stock price today?

China Everbright Limited (CEVIY) is currently trading at $5.40, up 0% today.

What is CEVIY P/E ratio?

China Everbright Limited's P/E ratio is -4.86. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CEVIY return on equity (ROE)?

China Everbright Limited's return on equity (ROE) is -6.64%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is China Everbright Limited's market cap?

China Everbright Limited has a market capitalization of $910.04M.

OTC · Asset Management

China Everbright Limited (CEVIY) Stock

$5.40 +0.00% OTC: CEVIY Financial Services

Valuation

Metric	Value
Price	$5.40
Market Cap	$910.04M
P/E Ratio	-4.86
P/B Ratio	0.36
P/S Ratio	3.65
EPS (TTM)	$-11.90
52-Week High	$7.35
52-Week Low	$5.40
Dividend Yield	2.41%

Financials & Margins

Metric	Value
ROE	-6.64%
ROA	-2.61%
ROCE	-1.60%
Gross Margin	98.29%
Operating Margin	-37.26%
Net Margin	-72.04%
Debt/Equity	1.22
Current Ratio	1.52

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$5.0B	$-5.0B	$5.9B	$5.5B	$1.6B
Operating Profit	$3.6B	$-7.0B	$4.4B	$4.4B	$-994.0M
Net Profit	$2.7B	$-7.4B	$-1.8B	$-1.8B	$-1.9B
EPS	$15.30	$-44.20	$-11.40	$-11.30	$-11.90
Op Margin	72.5%	139.4%	73.5%	79.8%	-63.4%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$101.8B	$84.5B	$79.6B	$74.7B	$73.8B
Total Liabilities	$53.1B	$48.9B	$45.5B	$42.0B	$45.5B
Cash	$7.2B	$8.9B	$9.6B	$8.4B	$8.5B
Borrowings	$35.0B	$33.0B	$34.6B	$30.2B	$33.5B

Latest News

Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms PR Newswire · Jul 29, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$2.1B	$-7.7B	$3.2B	$1.7B	$243.0M
Investing Cash Flow	$478.0M	$325.0M	$1.7B	$1.1B	$-593.0M
Financing Cash Flow	$-1.1B	$-1.3B	$-4.3B	$-1.4B	$48.0M
Net Cash Flow	$-2.0B	$1.1B	$1.6B	$-1.1B	$65.0M
Free Cash Flow	$2.0B	$-7.7B	$3.2B	$1.7B	$241.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-49.76
FCF Yield	6.98%
Quick Ratio	1.52
Interest Coverage	-1.11
Return 1Y	1.20%
Return 3Y	3.40%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AJMPFAshmore Group plc	$3.12	+0.00%	12.00	$2.03B	4.17%
CYMBFCymbria Corporation	$65.17	+0.00%	8.22	$1.42B	0.00%
DAHSFDah Sing Financial Holdings Limited	$3.34	+0.00%	6.60	$1.07B	10.78%
FFXDFFairfax India Holdings Corporation	$17.81	+0.03%	9.30	$1.86B	0.00%
GCAAFGuardian Capital Group Limited	$49.40	-0.22%	13.57	$1.21B	2.27%

About China Everbright Limited

China Everbright Limited is a diversified financial conglomerate that operates primarily in Hong Kong and Mainland China, with its core business encompassing both robust investment strategies and comprehensive financial service provisions. The company actively deploys capital into a wide array of ventures, specifically targeting unlisted equity securities and equity derivatives. Its strategic investment portfolio spans high-growth sectors such as the new economy, cutting-edge artificial intelligence, advanced manufacturing, renewable energy, and the medical and senior healthcare industries. Further areas of focus include overseas acquisitions and infrastructure projects, real estate, the aircraft industry value chain, and mezzanine financing solutions. Everbright also strategically targets platforms within burgeoning industries like aircraft leasing, Artificial Intelligence of Things (AIoT), and elderly care. Their investment instruments encompass equity, debt, and various structured products. Beyond its direct investments, China Everbright Limited delivers a broad spectrum of financial services. These include asset and investment management, alongside advisory services for a diverse range of funds, such as absolute return, bond, and equity funds. Additionally, the firm extends its expertise to provide management, treasury management, money lending, fund management, property and project investment, venture capital, leasing, and consultancy services. Established in 1997, the company maintains its headquarters in Hong Kong. China Everbright Limited operates as a subsidiary of Honorich Holdings Limited.

China Everbright Limited is headquartered in HK.

China Everbright Limited (CEVIY) stock trades at $5.40 with a market capitalization of $910.04M. The stock is valued at a price-to-earnings (P/E) ratio of -4.86, price-to-book of 0.36, price-to-sales of 3.65. Over the past 52 weeks the stock has ranged between $5.40 and $7.35, and currently trades 26.5% below its 52-week high. It pays a dividend yielding 2.41%.

On profitability, China Everbright Limited generates a return on equity (ROE) of -6.64%, return on capital employed of -1.60%, an operating margin of -37.26%, a net profit margin of -72.04%.

Official website: www.everbright.com